Stem cells in the treatment of myocardial injury-induced cardiomyopathy: mechanisms and efficient utilization strategies
Cardiac tissue injury and repair have always been a research hotspot in the field of cardiovascular disease. Limited and lost myocardial cells are non-renewable, and the current clinical treatment effect is still poor. The stem cells-based treatment strategy for cardiomyopathy is expected to solve t...
Saved in:
| Main Authors: | Jiali Yang, Tian Yue, Jian He, Shiqiang Xiong, Yan Luo, Jun Hou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1600604/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Melatonin and angiogenesis potential in stem cells
by: Somayyeh Rashidi, et al.
Published: (2025-08-01) -
Paracrine mechanisms of antiinflammatory and organoprotective effects in MSC transplantation
by: M. Sh. Khubutiya, et al.
Published: (2018-08-01) -
Intrapericardial injection of hydrogels with ASC and their secretome to treat dilated cardiomyopathies
by: Tácia Tavares Aquinas Liguori, et al.
Published: (2025-01-01) -
Deciphering influence of donor age on adipose-derived stem cells: in vitro paracrine function and angiogenic potential
by: Chloe Trotzier, et al.
Published: (2024-11-01) -
Case Report: Allogeneic adipose-derived mesenchymal stem cells for severe feline chronic kidney disease
by: Yizhe Song, et al.
Published: (2025-07-01)